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Abstract
Circadian rhythms are generated by an endogenously organized timing system that drives daily rhythms in behavior, physiology
and metabolism. In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus is the locus of a master circadian clock.
The SCN is synchronized to environmental changes in the light:dark cycle by direct, monosynaptic innervation via the retino-hypo-
thalamic tract. In turn, the SCN coordinates the rhythmic activities of innumerable subordinate clocks in virtually all bodily tissues
and organs. The core molecular clockwork is composed of a transcriptional/post-translational feedback loop in which clock genes
and their protein products periodically suppress their own transcription. This primary loop connects to downstream output genes
by additional, interlocked transcriptional feedback loops to create tissue-specific ‘circadian transcriptomes’. Signals from peripheral
tissues inform the SCN of the internal state of the organism and the brain’s master clock is modified accordingly. A consequence
of this hierarchical, multilevel feedback system is that there are ubiquitous effects of circadian timing on genetic and metabolic
responses throughout the body. This overview examines landmark studies in the history of the study of circadian timing system,




Daily changes in behavior and physiology have been known, most
likely, since prehistoric times. Initially, it was believed that daily
changes were not endogenously generated but were, instead, driven
by external temporal cues. Early evidence for the endogenous nature
of circadian rhythms came from a classic study by Jean-Jacques
d’Ortous de Mairan (1729) in which he investigated the daily leaf
motion in the heliotropic plant, Mimosa pudica (Somers, 1999). In
addition to its best-known behavior, where the leaves of M. pudica
rapidly fold inward when touched, the foliage of this plant also
closes during the night and reopens during the day. To examine
whether this rhythm was endogenous, de Mairan placed these plants
into constant darkness and monitored leaf movements. Despite hav-
ing been removed from the light:dark (LD) cycle, the plants in con-
stant darkness continued to show daily leaf movement with a period
close to 24 h.
Although the results of de Mairan’s work provided compelling
evidence for endogenous daily rhythms, it was argued, quite
plausibly, that daily changes in temperature or unspeciﬁed geophysi-
cal cues could be driving these oscillations. Although it was not their
intention, research by Nathanial Kleitman and his colleague, Bruce
Richardson, helped to provide further evidence for the endogenous
nature of circadian rhythms (Kleitman, 1939). With their goal being
to attempt to synchronize their sleep–wake cycle to a 28 h day, Kleit-
man and Richardson spent over a month in Mammoth Cave, Ken-
tucky, 150 feet below ground, where temperature and light were
constant. The younger Richardson was capable of modifying his
behavior to a 28 h day, whereas Kleitman was not, continuing to
sleep on an approximately 24 h schedule. Kleitman noted daily
rhythms in his body temperature, with peak efﬁciency occurring
when body temperature was highest. Although inconclusive given
the disparity between the two researchers, the fact that Kleitman’s
behavior and temperature oscillated with a 24 h cycle in the face of
28 h time cues suggested the existence of an endogenous clock.
Definitions and criteria
In nature, rhythmic responses that oscillate with ultradian (< 24 h),
infradian (> 24 h), circannual (~1 year) and circalunar (~29.5 days)
periods are known, but the molecular, cellular, network and behav-
ioral processes underlying these oscillations are understood only in
the case of circadian rhythms. That said, several criteria must be met
Correspondence: Dr Rae Silver, 2Department of Psychology, as above.
E-mail: QR@columbia.edu
Received 15 January 2014, revised 14 March 2014, accepted 19 March 2014
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd
European Journal of Neuroscience, Vol. 39, pp. 1866–1880, 2014 doi:10.1111/ejn.12593
in order to conﬁrm that a particular variable is under endogenous cir-
cadian control (as opposed to being driven by daily changes in the
environment). First, circadian rhythms should persist when animals
or tissues are removed from all daily temporal cues. This can be
tested by housing animals in constant darkness or by examining tis-
sues in culture. In addition, the response must persist for a minimum
of two or more cycles. In general, the ﬁrst 24 h interval following
placement into constant conditions is not part of this assessment, as
this ﬁrst cycle may be a consequence of the change in external condi-
tions or temporary rhythm maintenance following removal from a
driving stimulus. Thus, further conﬁdence that a rhythm is endoge-
nous is gained through observing additional cycles under such condi-
tions. Finally, the measured response should be entrained
(synchronized) to a daily temporal cue (e.g. the LD cycle) and resyn-
chronized to this entraining agent following phase adjustments.
Application of these criteria indicates that circadian rhythms are
ubiquitous.
Many molecular, cellular, physiological or behavioral measures
exhibit robust circadian rhythmicity. A dramatic example is seen in
the circadian oscillation of the liver-enriched transcriptional activator
protein, D-site of albumin promoter-binding protein (DBP), which is
not detectable in liver nuclei in the morning hours. DBP levels rise
during the afternoon and peak at about 20:00 h. During the night,
the cellular DBP concentration again decreases below detectability
(Wuarin & Schibler, 1990). Although somewhat more difﬁcult to
study, there are also circadian oscillations in gene expression in the
brain, and these are region-speciﬁc. For example, rhythmicity in
PER2 expression was described in 18 different brain regions, with
clusters of peaks at different times of day (Harbour et al., 2013).
Likewise, the transcriptional regulation of ~3–10% of genes in the
brain and periphery show daily rhythms (Akhtar et al., 2002; Duf-
ﬁeld et al., 2002; Miller et al., 2007; Hughes et al., 2009). In this
context, it is not surprising that there are pronounced daily rhythms
in cognitive functioning, e.g. the ability to learn and recall in ani-
mals held in an LD cycle or constant conditions (reviewed in Smarr
et al., 2014).
Implications for the research
As there are signiﬁcant circadian oscillations in many biological
responses, it is important to control for time of day when collecting
experimental data, as this can contribute signiﬁcantly to response vari-
ability. Direct assessment of circadian impact entails investigating a
phenomenon across the day and night. Without consideration of circa-
dian timing, one might fail to uncover the impact of experimental
manipulation. Furthermore, exposure to light, even brief exposure,
can lead to pronounced shifts in circadian phase. At night, light in ani-
mal facilities, from windows on doors, leakage around door frames, or
dim lights used for maintenance, can alter circadian rhythms of gene
expression, shift feeding times, increase body mass, reduce glucose
tolerance, alter melatonin rhythms and modulate oncogenicity (Minn-
eman et al., 1974; Dauchy et al., 1999; Fonken et al., 2010; Butler
et al., 2012). Such observations underscore the importance of taking
into consideration the time of day and photic environment when con-
ducting manipulations, tissue collection, or behavioral examinations.
Present goal
The foregoing background describes the phenomenology of circa-
dian rhythms and the criteria used in delineating endogenous con-
trolled processes. Today, it is clear that oscillations in functional
state impact broad swaths of neuroscience research. Our goal in the
present article is to provide a broad overview of the circadian timing
system for non-specialists and to underscore implications for circa-
dian timing in the study of neuroscience and behavior. In addition,
we highlight the signiﬁcance of circadian timing particularly for
researchers interested in feeding and metabolism, sleep biology,
mental health, sex differences, and the pharmacological treatment of
disease. Given the broad nature of this overview, our intention is to
point readers to key considerations of circadian timing for research
in the neurobiological basis of behavior, and to the recent literature,
rather than exhaustively reviewing literature on more limited aspects
of circadian rhythmicity.
Landmarks in the study of circadian rhythms
Modern history
Since the ﬁndings by de Mairan and Kleitman, numerous converg-
ing lines of evidence support the endogenous nature of circadian
timing. First, in constant conditions, the period of circadian rhythms
is approximately, but not precisely, 24 h. Were rhythms driven by
daily cues such as the LD cycle or geophysical signals, these cycles
would be precisely 24 h. Second, unlike most biological processes,
where increased temperatures hasten biochemical processes and
decreased temperatures have the opposite effect, circadian rhythms
are temperature compensated, such that the period of the rhythm is
unaltered by temperature changes (Pittendrigh & Caldarola, 1973).
This result rules out the possibility that daily changes in temperature
are responsible for circadian rhythmicity, although some rhythms
can be entrained to cycles in temperature. Together, these ﬁndings
provide strong suggestive evidence for the endogenous regulation of
circadian rhythms.
Suprachiasmatic nucleus as a brain master clock
The discovery of the suprachiasmatic nucleus (SCN) and its identiﬁ-
cation as a master brain clock launched the study of circadian
rhythms into a fruitful era of mechanistic studies. In 1972, two labo-
ratories showed that the destruction of a very discrete hypothalamic
area, the SCN, led to the permanent loss of circadian rhythms
(Moore & Eichler, 1972; Stephan & Zucker, 1972). The ﬁnding of a
neural locus for circadian timekeeping provides deﬁnitive evidence
for the endogenous control of circadian rhythmicity. In the two dec-
ades following the characterization of the SCN as a master circadian
clock, substantial support accumulated for the notion that, in mam-
mals, this hypothalamic nucleus is an internal timekeeper, with a
necessary role in circadian timing. The supporting evidence includes
proof that, both in vivo (Inouye & Kawamura, 1979) and in vitro
(Gillette & Prosser, 1988), the SCN is rhythmic when isolated from
the rest of the brain. When transplanted from a fetal donor animal
into an SCN-lesioned host, an SCN graft rescues rhythmicity and
the restored behavior has the period of the donor rather than the
host (Lehman et al., 1987; Ralph et al., 1990). In addition, the
molecular mechanisms responsible for rhythm generation at the cel-
lular level have been well characterized, and it has been shown that
genetic mutations or knockout of essential clock genes leads to
either arrhythmicity or gross deﬁcits in circadian timekeeping of the
SCN (Hastings et al., 2014; Partch et al., 2014).
The molecular clockwork
The SCN is comprised of about 20 000 cells that form a highly
organized network to produce a coherent, tissue-level clock (Welsh
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et al., 2010; Partch et al., 2014). At the cellular level, circadian
rhythms are generated by interlocked transcriptional/translational
feedback loops consisting of ‘clock’ genes and their protein products
(reviewed in Zhang & Kay, 2010; Hastings et al., 2014; Partch
et al., 2014) (Fig. 1). In mammals, the core feedback loop consists
of two transcriptional activators, CLOCK and BMAL1, and two
transcriptional repressors, the PERIOD (PER) and CRYPTO-
CHROME (CRY) proteins (Huang et al., 2012). In the morning,
CLOCK and BMAL1 activate transcription of the Per (Per1, Per2
and Per3) and Cry (Cry1 and Cry2) genes by binding to the E-box
(CACGTG) domain on their gene promoters. Over the course of the
day, the Per and Cry genes are translated into their respective pro-
teins. PER and CRY proteins form heterodimers late in the day that
translocate from the cytoplasm to the cell nucleus to inhibit
CLOCK:BMAL1-mediated transcription. The timing of nuclear
entry is balanced by regulatory kinases that phosphorylate the PER
and CRY proteins, leading to their degradation (Lowrey et al.,
2000; Shanware et al., 2011). REV-ERBa/ROR-binding elements
(Preitner et al., 2002) act to regulate Bmal1 transcription via a sec-
ondary feedback loop. The transcriptional retinoid-related orphan
receptor (ROR) is a transcriptional activator of Bmal1, whereas




Fig. 1. A decade ago, our understanding of the pacemaker was limited to a single ‘core’ loop, in which the transcriptional activators circadian locomotor out-
put cycles kaput (CLOCK) and brain and muscle ARNT-like 1 (BMAL1) dimerize and induce the expression of repressors PER and CRY, which feedback into
the loop to inhibit their own expression. (b) During the ﬁrst half of the past decade, a triple interlocking loops model was developed, including the PER–CRY
loop, which is the primary loop, and the ROR–REV–ERB-associated loop and D-site of albumin promoter-binding protein (DBP)–E4 promoter-binding protein
4 (E4BP4)-associated loop. In addition to the primary loop, which was previously recognized as the core loop (a), transcriptional regulation of CLOCK and
BMAL1 is controlled by ROR transcriptional activators and the dimeric REV–ERB repressors [by binding to REV response element (RRE)], the expression of
which is governed by CLOCK–BMAL1 activity (through binding to E-box-containing DNA elements). Furthermore, the transcriptional activator DBP (the
expression of which is controlled by an E-box) and E4BP4 (the expression of which is controlled by RRE) synergistically regulate the expression of D-box-con-
taining genes, including PER. (c) Hundreds of clock modiﬁers have now been identiﬁed through a genome-wide screen, some of which directly or indirectly
associate with known clock components. Genes that affect clock amplitude or period are shown in different colors. The dashed line circle indicates previously
known clock genes as shown in the triple interlocking loops (b). Reproduced from Zhang & Kay (2010), with permission (Nature Publishing Group).
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The same CLOCK:BMAL1 mechanism controlling Per and Cry
gene transcription also controls transcription of REV-ERBa. This
secondary feedback loop produces rhythmic expression of BMAL1,
further stabilizing the clockwork. The clockwork at the cellular level
is functionally similar across taxa, with interacting transcription/
translation feedback loops driving rhythms at the cellular level.
Importantly, clock genes themselves are not conserved across higher
taxa, but transcriptional feedback loops and post-transcriptional con-
trols are common mechanisms for the generation of cell-based oscil-
lation (reviewed in Harmer et al., 2001).
Circadian rhythms and temporal niche
Circadian oscillation is key to understanding how organisms are
synchronized to their local environments, and species-typical adapta-
tions to their temporal niches are markedly inﬂuenced by environ-
mental LD cycles (reviewed in Hut et al., 2012). As noted above, in
mammals, photic input from the retina entrains the SCN, but some-
what surprisingly, the phases of SCN electrical, metabolic and
molecular rhythms, relative to the light cycle, have the same day-
time peaks in diurnally and nocturnally active species (reviewed in
Smale et al., 2003). As an example, rhythms of Period gene expres-
sion in the SCN peak at approximately the same time of day in
diurnal as in nocturnal rodents, suggesting that the phase of clock
gene expression in the SCN relative to the LD cycle is conserved
across mammalian groups, and implying that the signaling cascade
initiating daily activity lay beyond the SCN. This phenomenon has
piqued the interest of investigators, especially because there is sig-
niﬁcant evidence that switching of temporal niches can occur (Mro-
sovsky & Hattar, 2005; Gattermann et al., 2008). It appears that
neural responses to light can mediate acute temporal-niche switch-
ing. Thus, a switch from nocturnal to diurnal activity rhythms
occurs in wild-type mice transferred from standard intensity to sco-
topic levels of light in an LD cycle (Doyle et al., 2008). A similar
switch from nocturnal to diurnal activity rhythms occurs in double-
knockout mice, bearing little rod function, due to a lack of the
inner-retinal photopigment melanopsin (OPN4) and of RPE65, a key
protein used in retinal chromophore recycling. Interestingly, the
rhythm of clock gene expression in the SCN is also reversed in
these mice, suggesting that the nocturnal to diurnal switch is due to
a change in the neural response to light upstream from the SCN. It
is possible that a common mechanism produces phase reversals in
Rpe65/;Opn4/ mice and in wild-type mice during dim LD
cycles.
Ubiquity of circadian oscillators
The identiﬁcation of ‘clock genes’ and the invention of reporter
gene technology enabled the assessment of rhythmicity in cultured
cells and tissues, such as SCN slice preparations. The technical
developments and experimental ﬁndings based on assessing the
activities of speciﬁc genes and proteins within cells and tissues has
led to a reconceptualization of the circadian organization as a hierar-
chy of oscillators. This vision has brought the circadian timing sys-
tem to the attention of a very broad clinical and basic research
community. Ignoring circadian effects leads to errors of interpreta-
tion in basic research and can result in suboptimal diagnosis and
treatments in medicine. Circadian clocks regulate the timing of gene
expression in each organ, and the regulated genes are unique to each
organ (Akhtar et al., 2002; Dufﬁeld et al., 2002; Miller et al., 2007;
Hughes et al., 2009; Dibner et al., 2010). Thus, circadian control
overlies the normal expression of tissue-speciﬁc genes and proteins.
Not surprisingly, the maintenance of normal phase relationships
among tissues and organs appears to be adaptive. Disrupting the cir-
cadian network can produce severe pathology (Litinski et al., 2009;
Karatsoreos et al., 2011). Optimizing the circadian timing system
for treatment, such as appropriately timing drug administration is a
frontier research area (Levi & Schibler, 2007; and see below).
Hierarchical organization of the circadian timing system
Since the discovery of the SCN, and the consistent ﬁnding that most
circadian rhythms are abolished following its destruction, it was
generally assumed that the SCN was the only locus capable of inde-
pendent circadian rhythm generation. In turn, all circadian rhythms
throughout the brain and body were thought to be driven by down-
stream communication from the SCN. This notion was challenged
following the observation that cultured ﬁbroblasts exhibit circadian
rhythms in gene expression following a serum shock (Balsalobre
et al., 1998). With this experiment, it became clear that the ability
to oscillate was a general property of tissues throughout the central
nervous system and periphery (Damiola et al., 2000; Yamazaki
et al., 2000; Yoo et al., 2004). The discovery that the SCN is not
alone in the capacity to express endogenous oscillation was the
beginning of a reconceptualization of the internal timekeeping
system (Balsalobre et al., 1998).
It is now known that the circadian system is composed of multi-
ple individual cellular oscillators located throughout the body and
most of its organs and glands. For example, a role for intrinsic
rhythmicity in other tissues has been demonstrated. An example of
SCN-independent timekeeping is seen in the olfactory bulb (Grana-
dos-Fuentes et al., 2006). SCN lesions eliminate circadian locomo-
tor rhythms, but not odor-induced c-Fos rhythms in the olfactory
bulb or piriform cortex. Olfactory bulb oscillators drive rhythms in
spontaneous and odor-evoked activity within the bulb and also in its
primary synaptic targets in the piriform cortex. In the sense that
olfactory bulb oscillators express circadian rhythms in the absence
of the SCN, persist in constant darkness and are required for
rhythms in the piriform cortex, these oscillators can be considered
master circadian pacemakers in the olfactory system. That said, in
the intact animal, under unperturbed conditions, the SCN sets the
phase of the olfactory bulb and other independent oscillators. The
SCN modulates temporal activity in these cellular oscillators, such
that each bears regulated phase relationships to SCN pacemakers
and hence to each other. Such ﬁndings led to the interpretation that
the circadian clock mechanism modulates the activity of genes in a
tissue-speciﬁc manner (Akhtar et al., 2002; Dufﬁeld et al., 2002;
Miller et al., 2007; Silver & Lesauter, 2008; Hughes et al., 2009).
This process can be accomplished either directly by CLOCK:
BMAL1 activation through an E-box domain on their gene promot-
ers (i.e. clock-controlled genes) or indirectly via downstream actions
of clock-controlled gene products to optimize system-wide function-
ing on a daily schedule (Fig. 2). For example, the thrombomodulin,
a cofactor for thrombin that is expressed on the surface of endothe-
lial cells to reduce blood coagulation, gene contains an E-box
domain in its promoter and is directly regulated by the CLOCK:
BMAL1 complex (Takeda et al., 2007). The resulting rhythm in
thrombomodulin probably contributes to daily changes in the likeli-
hood of cardiovascular events. Generally, the risk of cardiovascular
events peaks in the morning and evening; the morning time point is
associated with a daily peak in rhythmic cortisol and epinephrine,
whereas the night-time peak is associated with peak blood pressure
and a trough in cardiac vagal modulation (Scheer et al., 2010).
These broad implications expanded the audience of investigators
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and disciplines attending to the workings of the circadian timing
system. Not only were the salient phenomena, such as sleep–wake
cycles, of immediate interest, but also the invisible circadian oscilla-
tions such as seen in the workings of the heart, or in the timing of
cell division. Finally, the occurrence of sex differences in circadian
rhythms (Bailey & Silver, 2013) and the demonstration of diseases
associated with altered clock gene function rendered it necessary to
consider the circadian timing system in a broad array of apparently
unrelated disciplines, both applied and basic.
Unique features of the suprachiasmatic nucleus master clock
The ﬁnding of extra-SCN oscillators begged the question of the rela-
tionship of the brain master clock to these other clocks. What was
the unique aspect of the SCN that lent it master clock function?
Important discoveries included the ﬁnding that the cellular/molecular
mechanism of the clock was similar in the SCN and in other tissues
(Storch et al., 2002; Kamphuis et al., 2005; Liu et al., 2007; Miller
et al., 2007). Thus, clock functioning in cells outside the SCN is
equally vulnerable to disruption of the molecular clock (Liu et al.,
2007). Although the intracellular core clock molecular mechanisms
could not explain SCN master clock function, the unique pattern of
its connections appeared to be responsible, i.e. the coupling of its
neurons appeared to lend stability to the oscillation of the SCN tis-
sue, and its unique inputs and outputs appeared to be the basis of its
capacity to function as a master clock (Liu et al., 2007; Welsh
et al., 2010; Hastings et al., 2014). Unlike the SCN, rhythmic clock
gene expression in other central and peripheral tissues dampens
within a few days in culture, suggesting a loss of coupling among
oscillators that results in an inability to detect population-wide
rhythmicity (Balsalobre et al., 1998; Abe et al., 2002; Wilsbacher
et al., 2002). Indeed, this notion was conﬁrmed by monitoring the
single-cell bioluminescence of Per2::luciferase in mouse cultured ﬁ-
broblasts and establishing that, despite the loss of population-wide
rhythms in clock gene expression, single cells continued to show
clear rhythms in Per2 expression (Welsh et al., 2004; Leise et al.,
2012). These ﬁndings suggest that, in vivo, coherence among popu-
lations of subordinate oscillators is maintained through SCN com-
munication. Also dramatic is the observation that, although SCN
lesions abolish most circadian responses, some rhythms survive the
ablation of the SCN. For example, SCN-lesioned animals continue
to show circadian rhythms when treated with methamphetamine
(Honma & Honma, 2009) and they also continue to show food
anticipatory behavior, a response based on circadian timing (Saper,
2006; Patton & Mistlberger, 2013). These latter ﬁndings suggest that
the methamphetamine-entrainable oscillator and the food-entrainable
oscillator might share network coupling properties in common with
the SCN.
Although cellular oscillators are virtually ubiquitous, the SCN is
unique not only in terms of its ability to maintain rhythmic net-
work-level stability, but also in its direct access to timing informa-
tion. The SCN receives light information through a direct retino-
hypothalamic tract to synchronize the master clock to environmental
time (Morin & Allen, 2006). Historically, it was believed that the
only photoreceptors present in the retina were rods and cones. This
notion was questioned following the ﬁnding that mice lacking both
rod and cone photoreceptors (retinally degenerate mice) exhibit nor-
mal photic entrainment despite being visually blind (Foster et al.,
1993). By using a retrograde labeling strategy to identify retinal
cells projecting to the SCN, it was discovered that a subset of retinal
ganglion cells, expressing the photopigment melanopsin, were intrin-
sically photosensitive (Berson et al., 2002; Hannibal & Fahrenkrug,
2002; Hattar et al., 2002; Panda et al., 2002). As with the elimina-
tion of rod/cone signaling, elimination of melanopsin was not sufﬁ-
cient to abolish entrainment (Ruby et al., 2002; Lucas et al., 2003).
Entrainment is only fully prevented in mice doubly mutant for both
melanopsin and traditional rod/cone photoreceptors (Hattar et al.,
2003; Panda et al., 2003). Underscoring the importance of connec-
tivity, even though all photoreceptive classes can contribute to
entrainment, this occurs through the conduit of the intrinsically pho-
tosensitive retinal ganglion cells; ablating these cells alone (only
~2% of all retinal ganglion cells) prevents entrainment (Schmidt
et al., 2011). Together, these ﬁndings suggest that rod/cone photore-
ceptors project to intrinsically photosensitive retinal ganglion cells
that then send projections to the SCN to communicate this inte-
grated light information. Because subordinate oscillators do not have
access to light information, their phase relative to external time must
be maintained through communication from the master clock in the
SCN under light-entrained conditions.
Suprachiasmatic nucleus communication to central and
peripheral targets
As indicated previously, temporal harmony is maintained among
systems through SCN communication to central and peripheral tar-
gets. This coordination is essential for optimizing the timing of
behavioral and physiological events and maximizing health. The
Fig. 2. The hierarchical organization of the circadian system. The circadian
system is a hierarchy of similar cellular clock elements. The master clock of
the SCN achieves the ‘master’ role by virtue of the nucleus’s internal circuitry
and its ability to send timing signals to the rest of the brain. The SCN itself is
entrained to solar time and also receives information from arousal-related
activity of the body. Thus, the SCN integrates external and internal informa-
tion, and coordinates the rhythmic activities of peripheral oscillators to pro-
duce coherent timing in behavioral, autonomic, and endocrine functions.
Reproduced from Silver & Lesauter (2008), with permission (John Wiley and
Sons).
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SCN sets the phase relationship among various tissues via monosyn-
aptic neural targets, projections via the autonomic nervous system,
systemic hormone secretions, behavioral cycles of feeding and activ-
ity and the rhythmic alterations of body temperature (Kriegsfeld &
Silver, 2006; Reﬁnetti, 2010; Kalsbeek et al., 2011; Mavroudis
et al., 2012; Patton & Mistlberger, 2013; Sladek & Sumova, 2013).
The following section provides a brief overview of the speciﬁc
means by which information is communicated from the master clock
to target systems and considers the implications for physiological
and behavioral outcomes.
Neural suprachiasmatic nucleus communication
Prior to the advent of viral tract-tracing techniques, monosynaptic
anterograde and retrograde tracers were used to explore the connec-
tivity of the SCN to central targets (Stephan et al., 1981; Watts &
Swanson, 1987; Watts et al., 1987; Kalsbeek et al., 1993; Morin
et al., 1994; Leak & Moore, 2001; Kriegsfeld et al., 2004). These
studies revealed extensive monosynaptic projections proceeding ros-
trally to the septum and bed nucleus of the stria terminalis, rostrally
and dorsally to the thalamus, rostrally and laterally throughout the
hypothalamus, and caudally to the posterior paraventricular thala-
mus, precommissural nucleus and olivary pretectal nucleus. Given
these widespread projections, it is likely that the SCN is in a posi-
tion to communicate with the entire brain through secondary or ter-
tiary synapses originating from these primary target loci. In
addition, many of these target loci contain neuroendocrine cells and
hypothalamic releasing factors that can be secreted into the cerebro-
spinal ﬂuid or general circulation, providing pervasive communica-
tion to systems throughout the brain and body (van der Beek et al.,
1993; Vrang et al., 1995; Kalsbeek et al., 1996; Horvath, 1997;
Van der Beek et al., 1997; Buijs et al., 1998; Horvath et al., 1998;
Gerhold et al., 2001).
In addition to tract-tracing strategies to reveal SCN outputs, there
have been a number of studies to exploit novel behavioral patterns
that have been found to correlate with altered SCN rhythms. For
example, hamsters will spontaneously ‘split’ and exhibit two rest–
activity cycles each day instead of one when housed in constant
light. In a classic study, de la Iglesia et al. (2003) showed that, in
‘split’ hamsters, the right and left SCN oscillate out of phase with
each other, with each SCN’s molecular rhythms in phase with only
one of the two daily peaks of activity. Likewise, examination of
Per1::GFP expression in cultured SCNs from split mice shows anti-
phase oscillations that can be monitored for several cycles (Ohta
et al., 2005). Subsequent work using this split model revealed that,
rather than a simple right–left split, each SCN splits into two com-
partments that oscillate in antiphase (Tavakoli-Nezhad & Schwartz,
2005; Yan et al., 2005). This four-way split means that the split
hamsters’ SCNs exhibit 24 h rhythms of PER1 protein that cycles in
antiphase between the left and right sides and between core and shell
subregions. Associated with this SCN oscillation is a 12 h rhythm of
FOS expression in brain regions that receive SCN efferents (Butler
et al., 2012). In the target regions examined (medial preoptic area,
paraventricular nucleus of the hypothalamus, dorsomedial hypothala-
mus and orexin-A neurons), the oscillations were in-phase between
hemispheres (unlike in the SCN), although with detectable right–left
differences in amplitude. Importantly, in all three conditions studied
(split and unsplit hamsters in constant light, and control hamsters in
LD cycles), the timing of FOS expression in targets occurred at the
same time of day and always occurred at a common phase reference
point of the SCN oscillation, suggesting that, at a speciﬁc internal
phase, each SCN signals these targets once daily.
In addition to communication via direct projections to neural loci,
the SCN also sends multisynaptic connections, via the autonomic
nervous system, to targets in the periphery, setting the phase of sub-
ordinate oscillatory systems and controlling their activity. By apply-
ing transynaptic, retrograde viral tracers, such as a pseudo rabies
virus, to various organs and glands, precise multisynaptic connec-
tions from the SCN to the periphery have been established. Early
studies employing this technique established that corticosterone
secretion is controlled by direct projections to the adrenal gland (Buijs
et al., 1999), lipid mobilization via projections to adipose tissue
(Bamshad et al., 1998; Bartness & Bamshad, 1998; Bartness et al.,
2001; Demas & Bartness, 2001), ovarian function (Gerendai et al.,
1998, 2000; Gerendai & Halasz, 2000), and thyroid function (Kals-
beek et al., 2000). It is likely that neural connections from the SCN
to peripheral glands and organs may be universal for all targets in
the body.
Given the technical limitations of these tracers, it is not surprising
that several questions still remain. For example, does the SCN
employ the same cell phenotype(s) to communicate to all organs
and glands? Does the SCN communicate with one neurochemical
mediator, or a combination of neurochemical mediators, to set the
phase of subordinate oscillators? Is sympathetic and parasympathetic
control of peripheral tissues controlled by the same SCN cell pheno-
types? Technical innovations now permit an assessment of projec-
tions from speciﬁc neuropeptidergic cell phenotypes using viral
tracers driven by speciﬁc gene promoters. By applying these tools to
the SCN, important insight can be gained into the speciﬁc modalities
by which the SCN communicates to central and peripheral targets.
Diffusible signals
In addition to monosynaptic and multisynaptic neural projections,
several early lines of evidence suggested that a diffusible signal
from the SCN can sustain behavioral rhythmicity. First, in early
studies of SCN-lesioned hamsters, locomotor rhythmicity and rhyth-
mic gnawing behavior are restored following grafting of fetal SCN
tissue into the third ventricle of the lesioned host (Lehman et al.,
1987, 1995; Ralph et al., 1990; LeSauter & Silver, 1994). Postmor-
tem analysis indicated that few connections were made between the
graft and the host brain, suggesting that the re-establishment of
rhythmic behavior did not result from the restoration of SCN projec-
tions (Aguilar-Roblero et al., 1994; Lehman et al., 1995). Further-
more, when an ‘SCN island’ is created with a Halasz knife, animals
recover free-running rhythms, even though efferent ﬁbers from the
SCN have been severed (Inouye & Kawamura, 1979). Although it
is possible that efferent ﬁbers may have grown across the knife cut
to form correct synaptic connections, there is no evidence of such
plasticity in the mammalian brain.
More direct evidence for the existence of a diffusible SCN signal
was gained by transplanting SCN grafts encapsulated in a semi-por-
ous membrane that permitted diffusible, but not neural, outﬂow into
an SCN-lesioned host (Silver et al., 1996). In cases with viable
grafts, circadian locomotor rhythms were restored with the period of
the donor animal. These results demonstrate that the transplanted
biological clock can regulate rhythmicity by means of a diffusible
signal. Whether or not such a diffusible signal drives behavioral
rhythms under natural conditions has been a more challenging ques-
tion. Several candidate diffusible signals have been investigated
since these initial ﬁndings, including prokineticin-2 (Cheng et al.,
2002), transforming growth factor-alpha, and cardiotrophin-like
cytokine (Kramer et al., 2001; Cheng et al., 2002; Kraves & Weitz,
2006; Li et al., 2006, 2012). All three proteins are expressed
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rhythmically in the SCN and their receptors are present in major
SCN targets or around the third ventricle. The administration of
prokineticin-2 and transforming growth factor-alpha during the night
(when levels are typically low) inhibits wheel-running behavior,
whereas the administration of cardiotrophin-like cytokine antibody
during the day (when levels are typically low) leads to increased
daytime locomotor activity. Interestingly, in contrast to behavioral
rhythms, endocrine rhythms require neural output (Silver et al.,
1996 Nunez & Stephan, 1977; Meyer-Bernstein et al., 1999). It has
also been demonstrated that diffusible signals are sufﬁcient to pro-
duce oscillations in the SCN of non-rhythmic SCNs from mutant
animals. Thus, using a coculture technique in which a wild-type
SCN graft was used to examine the restoration of rhythmicity in
non-rhythmic mutant SCN, it was demonstrated that paracrine sig-
nals, involving vasoactive intestinal polypeptide, arginine vasopres-
sin and gastrin-releasing peptide, were sufﬁcient to restore cellular
synchrony and oscillation amplitude (Maywood et al., 2011). Like-
wise, in Cry double-knockout [Cry1(/)/Cry2(/)] mice, circa-
dian rhythms are synchronized in neonates but not in adults,
indicating a loss of rhythm synchrony in the course of development.
Whether a diffusible factor(s) in the SCN contributes to the coupling
of cellular circadian rhythms was investigated by coculture of a
non-bioluminescent SCN slice with a bioluminescent (PER2::lucifer-
ase) SCN slice. Synchronized circadian rhythms in adult Cry1
(/)/Cry2(/) SCN were restored by coculture of neonatal, but
not of juvenile, SCN. The results indicate that the neonatal SCN
produces a diffusible signal that supports the development of inter-
cellular networks that subserve coherent rhythm expression in adult
SCN (Ono et al., 2013).
Implications and consequences for the study of normal
physiology and behavior
In order to maximize survival and reproductive success, animals
restrict their behavior to optimal times of the day or night, and the cir-
cadian system is crucial for this temporal organization. In the absence
of a functional circadian system, survival and reproduction are com-
promised. For example, chipmunks in the Allegheny Mountains were
more vulnerable to predation following SCN lesions, presumably due
to inappropriate night-time restlessness revealing their location to pre-
dators (DeCoursey et al., 2000). In addition, in most spontaneously
ovulating female rodents, the SCN is essential for ovulation and sex-
ual behavior (Kriegsfeld & Silver, 2006; Christian & Moenter, 2010;
Tolson & Chappell, 2012). In women, disruptions to circadian timing
through shift work or jet lag also have pronounced negative conse-
quences for pregnancy and its maintenance (Mahoney, 2010). In addi-
tion to affecting reproduction, the circadian system impacts virtually
every behavioral or physiological system studied to date, and several
well-studied examples are presented below.
Feeding and circadian rhythms
The circadian system coordinates metabolism and food intake to
optimize feeding and with daily changes in digestion and nutrient
absorption (Tahara & Shibata, 2013). Mice with a mutation of the
Clock gene, for example, have greatly reduced daily rhythms in
feeding that lead to hyperphagia and obesity associated with ele-
vated lipids, leptin and glucose, and low insulin levels (Turek et al.,
2005). Likewise, high-fat-diet-induced obesity can be abrogated by
treatment with a Rev-erb agonist, reducing body fat and hyperglyce-
mia (Solt et al., 2012). Interestingly, the impact of circadian disrup-
tion on obesity occurs at the level of fat cells; site-speciﬁc deletion
of Bmal1 in mouse adipocytes leads to increased daytime feeding
and body mass, reduced locomotor activity and decreased circulating
levels of polyunsaturated fatty acids (Paschos et al., 2012). Recent
ﬁndings in humans indicate that sleep deprivation results in an
increased desire for high-caloric foods, and decreased frontal and
insular cortex activity and increased amygdala activity, as assessed
by functional magnetic resonance imaging (Greer et al., 2013).
Thus, the extent to which circadian disruptions lead to obesity
through disturbances to sleep represents an important opportunity
for further enquiry.
Circadian disruptions can arise from exposure to inappropriate
photic conditions. Exposure to dim (5 lux) light at night leads to
increased alterations in daily feeding and body mass along with
reduced rhythms of hypothalamic and liver clock gene expression in
mice (Fonken et al., 2013). The adverse impact of dim light at night
on metabolism, such as the dim red or white light used for animal
maintenance, can be ameliorated through wheel-running exercise or
subsequent exposure to dark at night (Fonken et al., 2014). There
has been substantial interest in the effect of light intensity and wave-
length on metabolic and other responses. In studies examining light,
effects controlling intensity, wavelength, and photoreceptor absorp-
tion spectra are taken into account. When wavelength is a question
of interest, then irradiance (incident power, in W/m2), rather than
illuminance (luminous ﬂux, in lux), is assessed. Measures of lux
provide a useful approximate mark that can ground a reader, but it
is a measure of perceived intensity by humans, a psychophysical
number comprising both the photoreceptor absorption of light and
the cognitive processing of that light. Because humans have a red-
sensitive cone, red that is perceived to be as bright as a reference
blue light (equal lux) would be much dimmer compared with the
blue to a mouse’s eye that lacks a red cone. Photosensitivity to dif-
ferent wavelengths is therefore better investigated with light sources
providing equal photon ﬂuxes (photosensitivity will still be wave-
length dependent, but this will be a measure of photoreceptor func-
tion and therefore transmission to the brain); a cell is agnostic to
wavelength once the photon has been absorbed. Light-emitting
diodes with narrow spectral emissions or notch ﬁlters facilitate these
investigations. Practicalities may force a reliance on incandescent
and ﬂuorescent lights but, because of their complex spectra, compar-
ing light of different colors is more difﬁcult. Illuminance measures
sufﬁce when wavelength per se is not a central focus.
The photosensitivity of a physiological or behavioral response to
light depends on what is being measured. This is important as the
photosensitivity of one response cannot be generalized to other func-
tions. As an example, measurements were made of the thresholds of
entrainment of wheel-running rhythms at three wavelengths, and
these were compared with the thresholds of two other non-image-
forming visual system functions, i.e. masking and the pupillary light
reﬂex. Dim light that entrained mice failed to elicit either masking
or pupillary light reﬂex; in general, circadian entrainment is more
sensitive by 1–2 log units than other measures of the non-image-
forming visual system. In an artiﬁcial photic environment, dim light
can entrain circadian rhythms even when it fails to produce more
easily measurable acute responses to light such as phase shifting
and melatonin suppression (Butler & Silver, 2011).
As mentioned previously, not only does the circadian system
inﬂuence feeding and metabolism, but food cues can also act to
entrain circadian rhythms (Saper, 2006; Patton & Mistlberger,
2013). If food presentation is restricted to a short temporal window
(typically a few hours), animals exhibit increased activity in antici-
pation of feeding [food anticipatory activity (FAA)]. Because this
synchronization of behavior with feeding persists in the absence of
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the SCN, a separate designation of the food entrainable oscillator
was coined (Stephan et al., 1979). The identiﬁcation of the neural
locus of the food-entrainable oscillator has been challenging. The
dorsomedial nucleus of the hypothalamus (DMH) probably plays a
role in food entrainment (Gooley et al., 2006; Fuller et al., 2008),
although mice and rats can entrain to food cues in the absence of a
DMH (Landry et al., 2006, 2007; Acosta-Galvan et al., 2011). In
mice, DMH lesions lead to reduced FAA, whereas lesions of both
the SCN and DMH result in enhanced FAA (Acosta-Galvan et al.,
2011). These ﬁndings suggest that the DMH participates in FAA,
but is not the sole neural locus of the food-entrainable oscillator. It
is likely that metabolic cues from the periphery, communicated to
the central nervous system, participate in food entrainment. For
example, ghrelin cells in the stomach that signal hunger express
clock genes, ghrelin administration leads to increased activity in ani-
mals fed ad libitum, and ghrelin and clock gene rhythms in these
stomach cells are synchronized to feeding (LeSauter et al., 2009).
Consistent with these ﬁndings, FAA is greatly reduced in ghrelin
receptor knockout mice (Blum et al., 2009; LeSauter et al., 2009).
These ﬁndings suggest that restricted feeding leads to entrainment of
stomach clocks in ghrelin-expressing cells and food-entrained ghre-
lin signaling feeds back to the central nervous system to drive
changes in FAA. Other neuronal systems including the hypocretin
arousal system (Akiyama et al., 2004; Mieda et al., 2004) and orex-
ogenic melanocortin system (Sutton et al., 2008; Patton & Mistlber-
ger, 2013) have been implicated in food entrainment, with
disruptions to either system causing pronounced deﬁcits in FAA.
Sleep–wakefulness and circadian rhythms
Most salient in daily life is the relationship between sleep and circa-
dian rhythmicity. Associated with the timing of the rest–activity
cycles are rhythms in alertness/drowsiness, mood, and other behav-
iors. These cycles, and the processes that they impact, are an
immense and fundamentally important topic, with much work in
basic, clinical and pharmacological aspects (reviewed in Murray &
Harvey, 2010; Harvey, 2011; Krystal et al., 2013; Saper & Sehgal,
2013). Although the details of sleep–circadian relationships are
beyond the scope of this review, we highlight some major aspects.
The relationship between circadian clocks and sleep involves two
interacting processes, and is captured in the classical opponent pro-
cess model of Borbely (1982). The homeostatic component of sleep
involves a process whereby the sleep pressure (termed process S)
increases the longer that an individual is awake. The neural locus
regulating this homeostatic pressure is not well deﬁned, and
involves multiple brain regions and transmitters (see below). In con-
trast, the circadian system that regulates the timing of wakefulness
and sleep has its well-characterized anatomical locus in the SCN.
The SCN has monosynaptic efferents to a number of nearby hypo-
thalamic regions (reviewed in Morin, 2013), and these in turn relay
information to a large number of brain regions, including those
involved in regulating awake and sleep states.
Sleep circuits
The neural circuits involved in sleep and arousal include the basal
forebrain, brainstem, and hypothalamic components. The SCN has
relatively few direct outputs to sleep–wake regulatory systems. Most
of its output projects to nearby hypothalamic regions that relay sig-
nals to sleep and wake regulatory regions. The sleep circuits are
comprised of numerous projections of neurons releasing different
types of neurotransmitters and neuropeptides (reviewed in Saper
et al., 2005) (Fig. 3). Brieﬂy, arousal pathways include cholinergic
neurons of the ascending arousal pathway, located in the
Fig. 3. (Left) A schematic drawing showing some key components of the ascending arousal system. A major input to the relay and reticular nuclei of the thalamus
(yellow pathway) originates from ACh cell groups in the upper pons, the PPT and LDT. These inputs facilitate thalamocortical transmission. A second pathway
(red) activates the cerebral cortex to facilitate the processing of inputs from the thalamus. This arises from neurons in the monoaminergic cell groups, including the
tuberomammillary nucleus (TMN) containing histamine (His), the A10 cell group containing DA, the dorsal and median raphe nuclei containing serotonin (5-HT),
and the LC containing NA. This pathway also receives contributions from peptidergic neurons in the LH containing ORX or MCH, and from BF neurons that con-
tain c-aminobutyric acid (GABA) or ACh. Note that all of these ascending pathways traverse the region at the junction of the brainstem and forebrain where von Ec-
onomo noted that lesions caused profound sleepiness. (Right) A schematic drawing to show the key projections of the VLPO to the main components of the
ascending arousal system. It includes the monoaminergic cell groups (red), such as the TMN, the A10 cell group, the raphe cell groups and the LC. It also innervates
neurons in the LHA (green), including the PeF ORX neurons, and interneurons in the ACh cell groups (yellow), the PPT and LDT. Note that the VLPO neurons lie
within the region outlined by von Economo for the anterior hypothalamic lesion that caused insomnia. ACh, cholinergic; BF, basal forebrain; DA, dopamine; Gal,
galanin; LC, locus coeruleus; LDT, laterodorsal tegmental nuclei; LH, lateral hypothalamus; MCH, melanin-concentrating hormone; NA, noradrenaline; ORX,
orexin; PAG, periaqueductal gray; PeF, perifornical; PPT, pedunculopontine. Adapted from Saper et al. (2005), with permission (Nature Publishing Group).
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pedunculopontine and laterodorsal tegmental nucleus, serotoninergic
neurons in the dorsal raphe nucleus, noradrenergic neurons in the
locus coeruleus, dopaminergic neurons in the median raphe nucleus,
and histaminergic neurons in the tuberomammillary nucleus of the
hypothalamus. Activity in these neurons promotes alertness and cor-
tical arousal. This system is inhibited by c-aminobutyric acid neu-
rons from the ventrolateral preoptic nucleus (VLPO) during sleep.
Speciﬁcally, the locus coeruleus provides norepinephrine-mediated
inhibition of the VLPO during wakefulness. During sleep, activity
in the ventral and median preoptic nuclei inhibits the ascending
arousal system via the inhibitory neurotransmitters c-aminobutyric
acid and galanin. The sleep-regulatory cells in the VLPO are
directly and indirectly regulated by SCN input (Novak & Nunez,
2000; Chou et al., 2002; Kriegsfeld et al., 2004). This circuit
enables master clock interactions with homeostatic sleep regulatory
systems. Among the most important known homeostatic sleep fac-
tors is adenosine (reviewed in Porkka-Heiskanen, 2013). The accu-
mulation of adenosine (a powerful somnogen) during wakefulness is
associated with increased VLPO activity upon increased adenosine
binding. VLPO activation then inhibits the ascending arousal circuits
and promotes non-rapid eye movement sleep.
Future directions
Sleep disturbances
It is beyond question that the most salient aspect of the circadian
system is its role in controlling the timing of sleep. Moreover, envi-
ronmental disruptions to circadian rhythms, including shift work,
travel across time zones, and irregular social schedules, tend to pre-
cipitate or exacerbate mood-related episodes. Using shift work or jet
lag as a model experimental paradigm, numerous studies, in both
humans and animals, have demonstrated the adverse effects of dis-
rupted sleep–wake schedules on health (Wang et al., 2011).
Nearly all people suffering from mood disorders have signiﬁcant
disruptions in circadian rhythms, and altered sleep patterns are one
of the major diagnostic criteria for these disorders. Importantly,
sleep disorders seem to precede clinical diagnoses of mental illness,
and reduction of sleep disturbances improves mental illness (Ritter
et al., 2011; Pritchett et al., 2012). It appears that many pathologies
are comorbid in both mental illness and neurodegenerative disease;
these include poor vigilance and memory, reduced mental and phys-
ical reaction times, reduced motivation, depression, insomnia, and
obesity, among other states (Wulff et al., 2010). Furthermore,
manipulation of the timing of sleep can ameliorate symptoms of
major depressive disorder and bipolar disorder (Bunney & Bunney,
2013; Kaplan & Harvey, 2013).
Although chronic sleep deprivation or disruption exacerbates
behavioral problems, and may directly affect cognitive function and
mood disorders, there is also evidence of mechanistic links between
circadian clocks, sleep and mental illness (reviewed in Lamont
et al., 2010; Menet & Rosbash, 2011). For example, in humans,
casein kinase 1 epsilon and PER2 mutations are associated with
familial advanced sleep phase disorder, which causes patients to fall
asleep several hours earlier than normal (Toh et al., 2001). In addi-
tion, associations for polymorphisms in other circadian genes,
including polymorphisms in the Cry2 locus with bipolar disorder
(Shi et al., 2008; Sjoholm et al., 2010) and depression (Lavebratt
et al., 2010), the Per3, Cry1, and timeless (Tim) genes with schizo-
phrenia and schizoaffective disorder, and Cry1, have been suggested
(Mansour et al., 2006; Lamont et al., 2007; Peng et al., 2007;
Moons et al., 2011). Bmal1 and Tim are associated with bipolar
disorder or schizophrenia (Mansour et al., 2006). Finally and
impressively, mistimed sleep in humans disrupts the molecular pro-
cesses associated with core clock gene expression and disrupts over-
all temporal organization throughout the body (Archer et al., 2014).
In summary, sleep disruption is associated with a wide range of
symptoms related to mental health.
Connecting circadian clocks to cellular metabolism
The current view of circadian clocks rests on a model of intracellu-
lar interlocked transcriptional and translational feedback loops that
generate circadian rhythms, with numerous post-translational and
post-transcriptional modiﬁcations (Partch et al., 2014). This well-
established landscape has started to move in a totally new direction
with the discovery of numerous cytosolic circadian loops central to
cellular physiology.
Several studies now point to metabolic rhythms that are indepen-
dent of transcription. These studies led to a search for the ways in
which the traditional transcription/translational feedback loops of
clock genes and their protein products are integrated with cytosolic
and metabolic components of cellular physiology. Over the years,
there have been hints of the existence of circadian oscillation in the
absence of transcriptional and translational feedback loops. A major
breakthrough was the demonstration that circadian oscillation could
be reconstituted in a test tube with a purely biochemical oscillator
(Nakajima et al., 2005).
A rhythmic, post-translational modiﬁcation of peroxiredoxin was
ﬁrst reported in mouse liver (Reddy et al., 2006). The dramatic
insight came from the discovery of circadian oscillations in human
red blood cells, which lack a nucleus and therefore lack the genetic
clock mechanism (O’Neill & Reddy, 2011; Edgar et al., 2012). The
peroxiredoxin family is part of the cellular defense against reactive
oxygen species, speciﬁcally H2O2, which are an unavoidable by-
product of aerobic metabolism. Red blood cells express peroxiredox-
in rhythms that are entrainable by temperature cycles, and are tem-
perature compensated. Circadian rhythms occur in the availability of
nicotinamide adenine dinucleotide, a coenzyme for energy conver-
sion in the cell, controlling the timing of oxidative metabolism in
mammalian mitochondria (Peek et al., 2013). These data suggest
that an underlying rhythmic capacity exists in the cytoplasm, not
directly reliant on nascent gene expression. The implication is that,
in nucleated cells, at a post-translational level, metabolic rhythms
interact reciprocally with transcriptional and translational feedback
loop elements known to regulate circadian timekeeping (Rey & Red-
dy, 2013) (Fig. 4). Circadian cross-talk between metabolic and tran-
scriptional clock components probably co-ordinates genome-wide
temporal, cell type-speciﬁc programs of gene expression. In this
way, circadian clocks exert regulatory control over almost every
aspect of physiology, with disruptions leading to disease states, and
their understanding lending opportunities for the analysis of novel
mechanisms of diagnosis and treatment.
Sex differences in circadian rhythms
An aspect of the circadian regulation of genetic, metabolic and cyto-
solic clocks that has received relatively little attention is how these
processes might be affected by sex differences. Also, sex differences
may confound the results of studies in which the sex of the animal
or cell is not taken into account. Within the brain, widespread sex
differences in gene expression and splicing have been detected in all
major brain regions and involve 2.5% of all expressed genes (Trabz-
uni et al., 2013). Furthermore, a diffusion tensor imaging study
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indicates widespread sex differences in regional and global network
characteristics of the brains of youths (Ingalhalikar et al., 2014).
The sparsity of circadian studies may be attributed in part to the
expense and work load associated with undertaking studies of both
males and females, especially when ovulatory cycle-associated
changes must also be taken into account (Morin et al., 1977). That
said, there are tremendous sex differences in the circadian timing
system (reviewed in Bailey & Silver, 2013). A salient example is
seen in sleep regulation. Women go to sleep later and later until the
age of around 19.5 years, whereas men continue to delay their sleep
until around the age of 21 years (Roenneberg et al., 2007). Further-
more, throughout adulthood, men tend to go to sleep later than
women. This sex difference disappears at around the age of 50, at
around the time of menopause.
A key symptom of major depressive disorder is the disruption of
circadian patterns. In a study applying time-of-death analysis to gene
expression data from postmortem brains, cyclic patterns of gene
expression were much weaker in the brains of patients with major
depressive disorders due to shifted peak timing and potentially dis-
rupted phase relationships between individual circadian genes (Li
et al., 2013). As noted above, sleep disturbance is associated with
major depressive disorders. Turning to the question of sex differ-
ences, Plante et al. (2012) found that women, but not men, with
major depressive disorders demonstrate signiﬁcant increases in slow
wave activity in multiple cortical areas relative to control subjects.
In conclusion, sex differences become important when they can pro-
vide clues to the mechanisms conferring protection to one sex or
susceptibility to the other, and in those research areas where sex dif-
ferences are salient, attention to the underlying mechanisms is espe-
cially warranted.
Circadian chronotherapeutics
It is now generally accepted that disruptions to the circadian timing
system hasten the progression, or contribute to the etiology, of a
number of disease states including cancer, cardiovascular disease,
neural cell death, peptic ulcers, obesity, rheumatoid arthritis, bipolar
disorder, depression and schizophrenia (reviewed in Golombek
et al., 2013). In addition to the impact of circadian disturbances on
disease, numerous studies in animal models and human clinical trials
indicate that there is pronounced impact on the efﬁcacy of a variety
of treatments based on the timing of their delivery. Early work in
rats and mice, for example, provided evidence that cancer chemo-
therapy was more efﬁcacious if delivered at times of greatest drug
tolerance (Halberg et al., 1980; Levi, 1987; Reinberg et al., 1987).
Later, it was recognized that cancer cells exhibit daily rhythms in
mitotic activity, and cytotoxic chemotherapeutic agents could be
most effectively applied during peak mitotic activity, ideally when
cell division is at a nadir in marrow and mucosal cells to avoid
damage to healthy tissues (Ortiz-Tudela et al., 2013). Despite
repeated clinical trials for a number of cancers revealing enormous
increases in response rate and survivorship and decreased negative
side-effects, it has been challenging to incorporate a chronotherapeu-
tic strategy into oncological practice. Part of the challenge arises
from the fact that sex, lifestyle, and genetic background inﬂuence
the most appropriate time of delivery across individuals (Ortiz-Tu-
dela et al., 2013). The ﬁnding of high-throughput, reliable circadian
biomarkers for host and cancerous tissues, along with the implemen-
tation of timed drug-delivery systems, is currently being explored to
bring chronotherapeutic approaches to the clinic.
More recently, it has become clear that vast improvements in the
efﬁcacy of pharmacological, in addition to chemotherapeutic, agents
can be gained by considering the timing of delivery. One strategy
that has met with success is to administer medication at a time of
greatest risk (e.g. myocardial infarction risk is greatest in the morn-
ing) or at the daily peak in the manifestation of the ailment (e.g.
asthma symptoms exhibit marked daily changes) (Bairy, 2013). A
more effective strategy is to consider daily changes in drug pharma-
codynamics and to deliver medications at a time when the drug is
best tolerated and metabolism and elimination are lowest. For over
300 drugs, prominent daily changes in absorption, distribution,
metabolism, and elimination have been noted (reviewed in Levi &
Schibler, 2007). By considering these daily changes in pharmacoki-
netics, striking increases in plasma concentrations of a drug can be
achieved simply by altering the timing of administration (e.g. Ollag-
nier et al., 1987; Smolensky et al., 1987; Bruguerolle, 1998)
(Fig. 5). In addition to maximizing the concentration of drugs and
minimizing their toxicity, drug targets exhibit daily changes that
alter the response, including erythrocyte permeability (Levi et al.,
Fig. 4. Circadian acetylation in the cell. Scheme representing plausible mecha-
nisms that the circadian clock might use to generate cytosolic and mitochondrial
acetylation rhythms. The activity of AcT, including CLOCK, together with
DeAc, might be controlled through transcriptional and post-transcriptional mech-
anisms. In addition, the circadian clock may also use the nicotinamide adenine
dinucleotide (NAD+)-dependent deacetylases SIRTs to modulate protein Ac,
because NAD+ levels are rhythmic in the cytosol. Reproduced from Rey &
Reddy (2013). © National Academy of Sciences of the United States of America.
Ac, acetylation; AcT, acetyltransferases; DeAc, deacetylases; SIRTs, sirtuins.
Fig. 5. Chronopharmacokinetics of indomethacin (75 mg/h) after oral
administration of a sustained release preparation; plasma concentrations of
indomethacin according to the time of administration in patients. Reproduced
from Bruguerolle (1998), with permission (Adis International Limited).
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1987; Bruguerolle & Prat, 1989) and receptor numbers/binding
afﬁnity (Redfern, 2003). Such strategies have been effectively
applied to the treatment of a variety of ailments that show marked
daily ﬂuctuations, including hypertension (Nayak et al., 2009; Her-
mida et al., 2014), asthma (Smolensky et al., 1987; Nainwal, 2012)
and rheumatoid arthritis (Cutolo, 2012). Given that differences in
the timing of symptoms for many conditions are similar across indi-
viduals, implementing chronotherapeutic strategies for the treatment
of some diseases is quite feasible and researchers and pharmaceuti-
cal companies are developing strategies to effectively deliver medi-
cations in a time-dependent fashion thorough time-release oral
administration, implants, and pumps (reviewed in Maroni et al.,
2010). Given the rapid advances in this emerging knowledge and
technology, it will be important to educate the medical community
in the magnitude of such effects and practical implementation of
chronotherapeutic approaches.
Concluding remarks
The cells of our brains and bodies have evolved in a 24 h solar sys-
tem in ways that enable optimal coordination of our internal and
external circadian cycles. Transcription–translation feedback loops
are modiﬁed by post-transcriptional regulatory processes, enabling a
central master clock to signal peripheral clocks that then exert local
control of cellular function speciﬁc to each organ and gland. Making
optimal use of circadian timing mechanisms within speciﬁc brain
regions and tissues will enable the understanding of interindividual
differences and development of pharmacological modulators of cir-
cadian timing identiﬁed from high-throughput screens. The hope is
that the robustness and resilience of circadian oscillation can be
enhanced, dysfunctional clocks can be repaired, and personalized
treatment regimens developed for age-related declines and treatment
of disease. Further information on mechanisms whereby the SCN
signals rhythmic gene expression in the rest of the brain and body
requires new genetic, mathematical and statistical tools to under-
stand the spatial and temporal changes in the circadian timing
system that underlie its normal and disrupted neural function.
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